US4336029A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and reagents for quantitative determination of reticulocytes and platelets in whole blood
Assignee: Ortho Clinical Diagnostics Inc
•
Filing: 1980-08-15
•
Granted: 1982-06-22
•
Expires: 2000-08-15
Abstract
Abstract Methods and compositions for quantitating reticulocytes and platelets by fluorescence in a flow cytometer. The composition comprises an aqueous solution of the dye acridine orange, citrate ion, and para-formaldehyde at a pH of about 7.4 and an isotonic osmolality. The concentrations of the various ingredients are selected to maximized dye uptake by the reticulocytes and platelets to allow for the first time the fluorescent quantitation of these cells in whole blood using a flow cytometer.
Inventors
- 👤 Peter J. Natale
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-26 17:06
CPC Classifications
G; G01; G01N; G01N15/00; G01N15/10; G01N15/14; G01N15/1456; G01N15/1459; G01N15/01; G01N2015/012; G01N2015/014; G01N2015/018
Claims Analysis
Total Claims: 6
Claim 1
Independent Claim
79 words
A dye composition for quantitation of reticulocytes and platelets in a whole blood sample by fluorescence using flow cytometry which consists essentially of an aqueous solution of an effective reticulocyte and platelet quantitating concentration of acridine orange dye, an effective magnesium ion chelating amount of citrate ion, and an effective maximum acridine uptake promoting concentration of an amino-reacting reagent; the aqueous solution having a pH of from about 7.3 to about 7.5 and having a physiological level of osmolality.
Claim 2
Dependent Claim
79 words
A dye composition for quantitation of reticulocytes and platelets in a whole blood sample by fluorescence using flow cytometry which consists essentially of an aqueous solution of an effective reticulocyte and platelet quantitating concentration of acridine orange dye, an effective magnesium ion chelating amount of citrate ion, and an effective maximum acridine uptake promoting concentration of an amino-reacting reagent; the aqueous solution having a pH of from about 7.3 to about 7.5 and having a physiological level of osmolality.
Claim 3
Dependent Claim
88 words
A dye composition useful for quantitating reticulocytes and platelets in a whole blood sample by fluorescence using flow cytometry which consists essentially of an aqueous solution of from about 0.008 grams per liter to about 0.012 grams per liter of acridine orange, from about 10.5 grams per liter to about 14 grams per liter of citric acid, from about 1.0 gram per liter to about 3.0 grams per liter of para-formaldehyde, and sufficient sodium hydroxide to bring the final pH of the solution to from 7.30 to 7.50.
Claim 4
Dependent Claim
88 words
A dye composition useful for quantitating reticulocytes and platelets in a whole blood sample by fluorescence using flow cytometry which consists essentially of an aqueous solution of from about 0.008 grams per liter to about 0.012 grams per liter of acridine orange, from about 10.5 grams per liter to about 14 grams per liter of citric acid, from about 1.0 gram per liter to about 3.0 grams per liter of para-formaldehyde, and sufficient sodium hydroxide to bring the final pH of the solution to from 7.30 to 7.50.
Claim 5
Dependent Claim
110 words
A method for quantitating reticulocytes or platelets in a whole blood sample by flow cytometry which comprises the steps of: (a) mixing a sample of blood to be tested with the reagent of claim 1 to form a suspension; (b) allowing the suspension to react for a sufficient time so that the acridine orange dye is maximally taken up by the reticulocytes and platelets; (c) exposing the suspension to radiation from a blue laser light source; (d) measuring the intensity of red fluorescence and amount of narrow forward scattered light from the suspension; and (e) determining the amount or percentage of reticulocytes or platelets in the sample from said measurements.
Claim 6
Dependent Claim
110 words
A method for quantitating reticulocytes or platelets in a whole blood sample by flow cytometry which comprises the steps of: (a) mixing a sample of blood to be tested with the reagent of claim 2 to form a suspension; (b) allowing the suspension to react for a sufficient time so that the acridine orange dye is maximally taken up by the reticulocytes and platelets; (c) exposing the suspension to radiation from a blue laser light source; (d) measuring the intensity of red fluorescence and amount of narrow forward scattered light from the suspension; and (e) determining the amount or percentage of reticulocytes or platelets in the sample from said measurements.
References Cited (Backward Citations)
US3497690A
Cited
US3684377A
Cited
US3864571A
Cited
US4027971A
Cited
US3916205A
Cited
US4146604A
Cited
US3997656A
Cited
US3883247A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1985-06-21 | 1985-12-21 | 1986-06-22 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1989-06-21 | 1989-12-21 | 1990-06-22 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1993-06-21 | 1993-12-21 | 1994-06-22 | $7700.00 | Window Closed / Lapsed |